A study of aspirin resistance in type 2 diabetes.

dc.contributor.authorSingla, Mani Kanten_US
dc.contributor.authorLahiri, Prabiren_US
dc.contributor.authorMukhopadhyay, Pradipen_US
dc.contributor.authorPandit, Kaushiken_US
dc.contributor.authorChaudhuri, Utpalen_US
dc.contributor.authorChowdhury, Subhankaren_US
dc.date.accessioned2008-11-17en_US
dc.date.accessioned2009-05-31T10:43:39Z
dc.date.available2008-11-17en_US
dc.date.available2009-05-31T10:43:39Z
dc.date.issued2008-11-17en_US
dc.description.abstractAspirin is currently known to give inadequate protection against coronary artery disease in diabetes compared to person without it. We evaluated 97 consecutive patients with type 2 diabetes for assessing laboratory aspirin resistance and attempted to assess the impact of various clinical and biochemical parameters on it. Thirty-eight patients (39.1%) were found to be less sensitive to the action of aspirin, 7 persons (7.2%) were found to be resistant and 31 persons (31.9%) were aspirin semi-responders. Only total cholesterol, LDL-cholesterol and triglyceride had statistically significant impact on aspirin resistance (p<0.05). Three persons out of 9 with some form of macrovascular disease had aspirin resistance.en_US
dc.description.affiliationDepartment of Endocrinology, IPGME&R and SSKM Hospital, Kolkata.en_US
dc.identifier.citationSingla MK, Lahiri P, Mukhopadhyay P, Pandit K, Chaudhuri U, Chowdhury S. A study of aspirin resistance in type 2 diabetes. Journal of the Indian Medical Association. 2008 Nov; 106(11): 720, 722-3, 740en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/99640
dc.language.isoengen_US
dc.source.urihttps://www.jimaonline.org.in/en_US
dc.subject.meshAspirin --administration & dosageen_US
dc.subject.meshCholesterol, LDL --blooden_US
dc.subject.meshCoronary Artery Disease --blooden_US
dc.subject.meshDiabetes Mellitus, Type 2 --blooden_US
dc.subject.meshDiabetic Angiopathies --blooden_US
dc.subject.meshDrug Resistanceen_US
dc.subject.meshHumansen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPlatelet Aggregation --drug effectsen_US
dc.subject.meshPlatelet Aggregation Inhibitors --administration & dosageen_US
dc.subject.meshPlatelet Function Testsen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshTriglycerides --blooden_US
dc.titleA study of aspirin resistance in type 2 diabetes.en_US
dc.typeJournal Articleen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description: